Skip to main content
OpenTrials

Clinical trial condition

Refractory ALK-Positive Large B-Cell Lymphoma

Explore clinical trials studying Refractory ALK-Positive Large B-Cell Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Refractory ALK-Positive Large B-Cell Lymphoma trial results

Recruiting

Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy

NCT06834373

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +39 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Mayo Clinic Health System in Albert Lea Albert Lea, Minnesota, United States
  • Mayo Clinic Health Systems-Mankato Mankato, Minnesota, United States
View Trial Details

Related conditions